These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 37909877)

  • 1. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
    Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
    CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.
    Shelley D; Wang VH; Taylor K; Williams R; Toll B; Rojewski A; Foley KL; Rigotti N; Ostroff JS
    Transl Behav Med; 2022 Nov; 12(11):1076-1083. PubMed ID: 36227937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung Cancer Screening in the US, 2022.
    Bandi P; Star J; Ashad-Bishop K; Kratzer T; Smith R; Jemal A
    JAMA Intern Med; 2024 Aug; 184(8):882-891. PubMed ID: 38856988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
    Oeffinger KC; Fontham ET; Etzioni R; Herzig A; Michaelson JS; Shih YC; Walter LC; Church TR; Flowers CR; LaMonte SJ; Wolf AM; DeSantis C; Lortet-Tieulent J; Andrews K; Manassaram-Baptiste D; Saslow D; Smith RA; Brawley OW; Wender R;
    JAMA; 2015 Oct; 314(15):1599-614. PubMed ID: 26501536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Krist AH; Davidson KW; Mangione CM; Barry MJ; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Kubik M; Landefeld CS; Li L; Ogedegbe G; Owens DK; Pbert L; Silverstein M; Stevermer J; Tseng CW; Wong JB
    JAMA; 2021 Mar; 325(10):962-970. PubMed ID: 33687470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force.
    Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT
    JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Cancer Society lung cancer screening guidelines.
    Wender R; Fontham ET; Barrera E; Colditz GA; Church TR; Ettinger DS; Etzioni R; Flowers CR; Gazelle GS; Kelsey DK; LaMonte SJ; Michaelson JS; Oeffinger KC; Shih YC; Sullivan DC; Travis W; Walter L; Wolf AM; Brawley OW; Smith RA
    CA Cancer J Clin; 2013; 63(2):107-17. PubMed ID: 23315954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
    Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih YT; Walter LC; Andrews KS; Brawley OW; Brooks D; Fedewa SA; Manassaram-Baptiste D; Siegel RL; Wender RC; Smith RA
    CA Cancer J Clin; 2018 Jul; 68(4):250-281. PubMed ID: 29846947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
    Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
    Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit-to-radiation-risk of low-dose computed tomography lung cancer screening.
    Hendrick RE; Smith RA
    Cancer; 2024 Jan; 130(2):216-223. PubMed ID: 37909872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung Cancer Screening at a Military Treatment Facility: A Retrospective Review.
    White LJ; Kaur A; Lapel RT; E Boswell G; Luceri RE; Parrish JS; Seda G
    Mil Med; 2020 Jun; 185(5-6):e864-e869. PubMed ID: 31925432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer risk by years since quitting in 30+ pack year smokers.
    Pinsky PF; Zhu CS; Kramer BS
    J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: A simulation modeling study.
    Meza R; Cao P; de Nijs K; Jeon J; Smith RA; Ten Haaf K; de Koning H
    Cancer; 2024 Jan; 130(2):244-255. PubMed ID: 37909874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals.
    Gudina AT; Kamen C; Hardy SJ; Kehoe L; Culakova E; Cupertino AP
    Lung Cancer; 2024 May; 191():107539. PubMed ID: 38552545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
    de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
    Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for lung cancer with computed tomography: protocol for systematic reviews for the Canadian Task Force on Preventive Health Care.
    Pillay J; Rahman S; Klarenbach S; Reynolds DL; Tessier LA; Thériault G; Persaud N; Finley C; Leighl N; McInnes MDF; Garritty C; Traversy G; Tan M; Hartling L
    Syst Rev; 2024 Mar; 13(1):88. PubMed ID: 38493159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.